Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3332/ecancer.2017.727 http://scihub22266oqcxt.onion/10.3332/ecancer.2017.727 C5365336!5365336!28386297     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ecancermedicalscience 2017 ; 11 (ä): ä Nephropedia Template TP {{tp|p=28386297|t=2017. Low-value practices in oncology contributing to financial toxicity |pdf=|usr=}}{{28386297}} gab.com Text Low-value practices in oncology contributing to financial toxicity JO: Ecancermedicalscience http://www.kidney.de/pget.php?&tw=1&pmid=28386297 #FOAvip Financial toxicity of cancer treatment is now a well-recognised problem in cancer medicine leading to patient bankruptcy and even poor survival, including in high-income countries and countries with public health care systems. Many oncologists, despite acknowledging the severity of financial toxicity as a problem, resign the responsibility of reducing the costs of cancer treatment to the government, industry, and oncology societies. However, an oncologist can play an important role in reducing the costs of cancer treatment because all cancer treatment decisions are made between the oncologist and the patient. In this article, I point out a few examples of low value practices from various oncology disciplines that we oncologists can easily replace or abandon in our practice and contribute to lessening the financial toxicities to patients and society. As these examples suggest, reducing cost does not necessarily mean compromising efficacy. We should continuously keep looking for other similar cost-saving strategies in our practice. Twit Text FOAVip Low-value practices in oncology contributing to financial toxicity ????Ecancermedicalscience http://www.kidney.de/pget.php?&tw=1&pmid=28386297 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28386297 #FOAvip English Wikipedia <ref>{{Cite pmid|28386297}}</ref> Low-value practices in oncology contributing to financial toxicity #MMPMID28386297 Gyawali B Ecancermedicalscience 2017[]; 11 (ä): ä PMID28386297show ga Financial toxicity of cancer treatment is now a well-recognised problem in cancer medicine leading to patient bankruptcy and even poor survival, including in high-income countries and countries with public health care systems. Many oncologists, despite acknowledging the severity of financial toxicity as a problem, resign the responsibility of reducing the costs of cancer treatment to the government, industry, and oncology societies. However, an oncologist can play an important role in reducing the costs of cancer treatment because all cancer treatment decisions are made between the oncologist and the patient. In this article, I point out a few examples of low value practices from various oncology disciplines that we oncologists can easily replace or abandon in our practice and contribute to lessening the financial toxicities to patients and society. As these examples suggest, reducing cost does not necessarily mean compromising efficacy. We should continuously keep looking for other similar cost-saving strategies in our practice. äLow-value practices in oncology contributing to financial toxicity (epmc).pdf DeepDyve Pubget Overpricing